Mitoxantrone

ATC CODE

  • L01DB07

INDICATION

  • General oncology.

NEMLC RECOMMENDATION

  • Approved
    Indications for consideration: Advanced stage carcinomas, paediatric relapsed acute lymphoblastic leukaemia (ALL) , paediatric acute myeloid leukaemia (AML) .

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 30 June 2016